ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition.
Authors: Ge LP, Xiao YL, Wu SY, Zhang FL, Lee ER, Di GH, Shao ZM, Shen M, Jiang YZ
Journal: Nature communications
group therapy
mental health
open access